Cargando…

Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations

PURPOSE: Extrinsic factors and genetic predisposition contribute to the etiology of sarcoidosis, converging in a phenotype of altered immune response associated with multisystemic inflammatory granulomatous tissue infiltration. Immunological reconstitution after hematopoietic stem cell transplantati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wurm-Kuczera, Rebecca Isabel, Buentzel, Judith, Koenig, Julia Felicitas Leni, Legler, Tobias, Valk, Jan-Jakob, Hasenkamp, Justin, Jung, Wolfram, Rademacher, Jan-Gerd, Korsten, Peter, Wulf, Gerald Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529157/
https://www.ncbi.nlm.nih.gov/pubmed/34691055
http://dx.doi.org/10.3389/fimmu.2021.746996
_version_ 1784586408691761152
author Wurm-Kuczera, Rebecca Isabel
Buentzel, Judith
Koenig, Julia Felicitas Leni
Legler, Tobias
Valk, Jan-Jakob
Hasenkamp, Justin
Jung, Wolfram
Rademacher, Jan-Gerd
Korsten, Peter
Wulf, Gerald Georg
author_facet Wurm-Kuczera, Rebecca Isabel
Buentzel, Judith
Koenig, Julia Felicitas Leni
Legler, Tobias
Valk, Jan-Jakob
Hasenkamp, Justin
Jung, Wolfram
Rademacher, Jan-Gerd
Korsten, Peter
Wulf, Gerald Georg
author_sort Wurm-Kuczera, Rebecca Isabel
collection PubMed
description PURPOSE: Extrinsic factors and genetic predisposition contribute to the etiology of sarcoidosis, converging in a phenotype of altered immune response associated with multisystemic inflammatory granulomatous tissue infiltration. Immunological reconstitution after hematopoietic stem cell transplantation (HSCT) may represent a unique window for the pathogenesis of the disease. We describe the incidence, clinicopathological features, and HLA associations of sarcoidosis after HSCT in a single-center cohort of patients, together with data from previously published cases. METHODS: We retrospectively analyzed clinical characteristics and HLA haplotypes from allogeneic (allo) or autologous (auto) HSCT patients from January 2001 through May 2021 at the University Medicine Goettingen (UMG), and data from previously published cases. RESULTS: A total number of 19 patients was identified. These included 4 patients from our center (3 allo HSCT and 1 auto HSCT) and 15 patients from the literature review. Thirteen patients had received an allo HSCT, and six patients had received an auto HSCT. Sarcoidosis occurred after a median interval of 20 (after allo HSCT) and 7 (after auto HSCT) months, respectively. The predominant HLA allele associated with sarcoidosis was HLA DRB1*03:01. Sarcoidosis involved the respiratory tract in 15 patients (three unknown, one without pulmonary involvement), and it was associated with graft-versus-host disease in 7 of 13 patients receiving allo HSCT. None of the donors or patients had a history of sarcoidosis before transplantation. Disease manifestations resolved with standard glucocorticoid treatment without long-term sequelae. CONCLUSION: Sarcoidosis may occur at low frequency during reconstitution of the immune system after HSCT. HLA allele associations reflect the associations observed in the general population, particularly with DRB1*03:01. Further insights into the interplay between Tcell reconstitution and the development of sarcoidosis could also provide novel approaches to an improved understanding of the pathogenesis in sarcoidosis.
format Online
Article
Text
id pubmed-8529157
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85291572021-10-22 Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations Wurm-Kuczera, Rebecca Isabel Buentzel, Judith Koenig, Julia Felicitas Leni Legler, Tobias Valk, Jan-Jakob Hasenkamp, Justin Jung, Wolfram Rademacher, Jan-Gerd Korsten, Peter Wulf, Gerald Georg Front Immunol Immunology PURPOSE: Extrinsic factors and genetic predisposition contribute to the etiology of sarcoidosis, converging in a phenotype of altered immune response associated with multisystemic inflammatory granulomatous tissue infiltration. Immunological reconstitution after hematopoietic stem cell transplantation (HSCT) may represent a unique window for the pathogenesis of the disease. We describe the incidence, clinicopathological features, and HLA associations of sarcoidosis after HSCT in a single-center cohort of patients, together with data from previously published cases. METHODS: We retrospectively analyzed clinical characteristics and HLA haplotypes from allogeneic (allo) or autologous (auto) HSCT patients from January 2001 through May 2021 at the University Medicine Goettingen (UMG), and data from previously published cases. RESULTS: A total number of 19 patients was identified. These included 4 patients from our center (3 allo HSCT and 1 auto HSCT) and 15 patients from the literature review. Thirteen patients had received an allo HSCT, and six patients had received an auto HSCT. Sarcoidosis occurred after a median interval of 20 (after allo HSCT) and 7 (after auto HSCT) months, respectively. The predominant HLA allele associated with sarcoidosis was HLA DRB1*03:01. Sarcoidosis involved the respiratory tract in 15 patients (three unknown, one without pulmonary involvement), and it was associated with graft-versus-host disease in 7 of 13 patients receiving allo HSCT. None of the donors or patients had a history of sarcoidosis before transplantation. Disease manifestations resolved with standard glucocorticoid treatment without long-term sequelae. CONCLUSION: Sarcoidosis may occur at low frequency during reconstitution of the immune system after HSCT. HLA allele associations reflect the associations observed in the general population, particularly with DRB1*03:01. Further insights into the interplay between Tcell reconstitution and the development of sarcoidosis could also provide novel approaches to an improved understanding of the pathogenesis in sarcoidosis. Frontiers Media S.A. 2021-10-07 /pmc/articles/PMC8529157/ /pubmed/34691055 http://dx.doi.org/10.3389/fimmu.2021.746996 Text en Copyright © 2021 Wurm-Kuczera, Buentzel, Koenig, Legler, Valk, Hasenkamp, Jung, Rademacher, Korsten and Wulf https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wurm-Kuczera, Rebecca Isabel
Buentzel, Judith
Koenig, Julia Felicitas Leni
Legler, Tobias
Valk, Jan-Jakob
Hasenkamp, Justin
Jung, Wolfram
Rademacher, Jan-Gerd
Korsten, Peter
Wulf, Gerald Georg
Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations
title Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations
title_full Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations
title_fullStr Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations
title_full_unstemmed Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations
title_short Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations
title_sort sarcoidosis following hematopoietic stem cell transplantation: clinical characteristics and hla associations
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529157/
https://www.ncbi.nlm.nih.gov/pubmed/34691055
http://dx.doi.org/10.3389/fimmu.2021.746996
work_keys_str_mv AT wurmkuczerarebeccaisabel sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations
AT buentzeljudith sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations
AT koenigjuliafelicitasleni sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations
AT leglertobias sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations
AT valkjanjakob sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations
AT hasenkampjustin sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations
AT jungwolfram sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations
AT rademacherjangerd sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations
AT korstenpeter sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations
AT wulfgeraldgeorg sarcoidosisfollowinghematopoieticstemcelltransplantationclinicalcharacteristicsandhlaassociations